Literature DB >> 17357842

Development of pancreatic acinar cell metaplasia after successful administration of omeprazole for 6 months in rats.

Tadashi Hagiwara1, Ken-ichi Mukaisho, Zhi-Qiang Ling, Hiroyuki Sugihara, Takanori Hattori.   

Abstract

Long-term use of proton pump inhibitors (PPIs) has been reported to worsen corpus atrophic gastritis in patients with Helicobacter pylori infection. On the other hand, PPIs have been associated with fundic gland-type gastric polyps and various histological changes. In the present study, we attempted to establish a protocol for omeprazole (OPZ) administration to rats over a longer period and examined the morphological changes in the gastric mucosa after administration of OPZ for 6 months. A total of 34 Wistar rats (8 weeks old) were used. In a preliminary experiment to determine the appropriate dose of OPZ, the rats had ad libitum access to food containing different doses of OPZ for 1 month. We found an approximate dose of 100 mg/kg body weight/day of OPZ to be most suitable from the point of view of intragastric pH, body weight, and serum gastrin level. In the experiment proper, rats were divided into two groups, either control or OPZ diets, and morphological changes in the gastric mucosa in each group were then examined by hematoxylin and eosin and immunohistochemical staining with alpha-amylase, trypsin, and chromogranin A. Multiple vacuolar degeneration of parietal cells and numerous small mucous cells were evident at 1 month after treatment with OPZ. At 6 months after treatment with OPZ, cystic degeneration and acinar-cell-like cells containing red granules positive for alpha-amylase and trypsin and negative for chromogranin A were detected in the OPZ rats. The serum gastrin level in the OPZ group was significantly higher than that in the control group. We have established a protocol for long-term administration of OPZ in rats that is a useful model for analyzing morphological changes after long-term PPI therapy. Long-term OPZ treatment causes hypergastrinemia and pancreatic acinar cell metaplasia in this animal model.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17357842     DOI: 10.1007/s10620-006-9253-7

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN: 0163-2116            Impact factor:   3.487


  26 in total

1.  Gastric polyposis: onset during long-term therapy with omeprazole.

Authors:  J R Graham
Journal:  Med J Aust       Date:  1992-08-17       Impact factor: 7.738

2.  Endoscopic and histological appearance of pancreatic metaplasia in the human gastric mucosa: a preliminary report on a recently recognized new type of gastric mucosal metaplasia.

Authors:  J Stachura; J W Konturek; K Urbanczyk; J Bogdal; T Mach; W Domschke
Journal:  Eur J Gastroenterol Hepatol       Date:  1996-03       Impact factor: 2.566

3.  [The effect of omeprazole, a proton pump inhibitor, on ontogeny of rat gastric mucosa, with special reference to cell proliferation and DNA synthesis].

Authors:  T Kawai; K Kawai; H Inokuchi; T Azuma; Z Sasaki; T Seki; Y Harada; T Saito
Journal:  Nihon Shokakibyo Gakkai Zasshi       Date:  1987-07

4.  Omeprazole-induced pseudohypertrophy of gastric parietal cells.

Authors:  M Stolte; B Bethke; G Rühl; M Ritter
Journal:  Z Gastroenterol       Date:  1992-02       Impact factor: 2.000

5.  Fundic gland polyps developing during omeprazole therapy.

Authors:  H M el-Zimaity; F W Jackson; D Y Graham
Journal:  Am J Gastroenterol       Date:  1997-10       Impact factor: 10.864

6.  Gastric polyps and nodules in children receiving long-term omeprazole therapy.

Authors:  Dinesh S Pashankar; David M Israel
Journal:  J Pediatr Gastroenterol Nutr       Date:  2002-11       Impact factor: 2.839

7.  Observation of gastric glandular cysts in the corpus mucosa of the stomach under omeprazole treatment.

Authors:  M Stolte; B Bethke; E Seifert; U Armbrecht; A Lütke; P Goldbrunner; U Rabast
Journal:  Z Gastroenterol       Date:  1995-03       Impact factor: 2.000

8.  Substituted benzimidazoles inhibit gastric acid secretion by blocking (H+ + K+)ATPase.

Authors:  E Fellenius; T Berglindh; G Sachs; L Olbe; B Elander; S E Sjöstrand; B Wallmark
Journal:  Nature       Date:  1981-03-12       Impact factor: 49.962

9.  Development of Helicobacter pylori-induced gastric carcinoma in Mongolian gerbils.

Authors:  S Honda; T Fujioka; M Tokieda; R Satoh; A Nishizono; M Nasu
Journal:  Cancer Res       Date:  1998-10-01       Impact factor: 12.701

10.  Increase of Helicobacter pylori-associated corpus gastritis during acid suppressive therapy: implications for long-term safety.

Authors:  E J Kuipers; A M Uyterlinde; A S Peña; H J Hazenberg; E Bloemena; J Lindeman; E C Klinkenberg-Knol; S G Meuwissen
Journal:  Am J Gastroenterol       Date:  1995-09       Impact factor: 10.864

View more
  9 in total

1.  Clinicopathological characteristics of pancreatic acinar cell metaplasia associated with Helicobacter pylori infection.

Authors:  Takafumi Fuchino; Yasuhiro Wada; Masaaki Kodama; Ken-Ichi Mukaisho; Kazuhiro Mizukami; Tadayoshi Okimoto; Ryoji Kushima; Kazunari Murakami
Journal:  BMC Gastroenterol       Date:  2022-06-07       Impact factor: 2.847

2.  Pancreatic acinar metaplasia in the distal oesophagus and the gastric cardia: prevalence, predictors and relation to GORD.

Authors:  Johan Johansson; Hans-Olof Håkansson; Lennart Mellblom; Antti Kempas; Gerhard Kjellén; Lars Brudin; Fredrik Granath; Karl-Erik Johansson; Olof Nyrén
Journal:  J Gastroenterol       Date:  2009-12-15       Impact factor: 7.527

3.  Bravo capsule system optimizes intragastric pH monitoring over prolonged time: effects of ghrelin on gastric acid and hormone secretion in the rat.

Authors:  Tobias Rudholm; Per-Mikael Hellstrom; Elvar Theodorsson; Colin-Allan Campbell; Peter-Geoffrey McLean; Erik Naslund
Journal:  World J Gastroenterol       Date:  2008-10-28       Impact factor: 5.742

4.  Pancreatic acinar cells--a normal finding at the gastroesophageal junction? Data from a prospective Central European multicenter study.

Authors:  Nora I Schneider; Wolfgang Plieschnegger; Michael Geppert; Bernd Wigginghaus; Gabriele M Höss; Andreas Eherer; Eva-Maria Wolf; Peter Rehak; Michael Vieth; Cord Langner
Journal:  Virchows Arch       Date:  2013-08-29       Impact factor: 4.064

5.  Rebamipide contributes to reducing adverse effects of long-term administration of omeprazole in rats.

Authors:  Tadashi Hagiwara; Ken-ichi Mukaisho; Zhi-Qiang Ling; Takayo Sakano; Hiroyuki Sugihara; Takanori Hattori
Journal:  Dig Dis Sci       Date:  2007-03-07       Impact factor: 3.199

6.  Role of proton pump inhibitor on esophageal carcinogenesis and pancreatic acinar cell metaplasia development: an experimental in vivo study.

Authors:  Luigi Dall'Olmo; Matteo Fassan; Elisa Dassie; Marco Scarpa; Stefano Realdon; Francesco Cavallin; Matteo Cagol; Giorgio Battaglia; Marco Pizzi; Vincenza Guzzardo; Erica Franceschinis; Gianfranco Pasut; Massimo Rugge; Giovanni Zaninotto; Nicola Realdon; Carlo Castoro
Journal:  PLoS One       Date:  2014-11-21       Impact factor: 3.240

Review 7.  Pharmacological Effects and Toxicogenetic Impacts of Omeprazole: Genomic Instability and Cancer.

Authors:  Márcia Fernanda Correia Jardim Paz; Marcus Vinícius Oliveira Barros de Alencar; Rodrigo Maciel Paulino de Lima; André Luiz Pinho Sobral; Glauto Tuquarre Melo do Nascimento; Cristiane Amaral Dos Reis; Maria do Perpetuo Socorro de Sousa Coêlho; Maria Luísa Lima Barreto do Nascimento; Antonio Luiz Gomes Júnior; Kátia da Conceição Machado; Ag-Anne Pereira Melo de Menezes; Rosália Maria Torres de Lima; José Williams Gomes de Oliveira Filho; Ana Carolina Soares Dias; Antonielly Campinho Dos Reis; Ana Maria Oliveira Ferreira da Mata; Sônia Alves Machado; Carlos Dimas de Carvalho Sousa; Felipe Cavalcanti Carneiro da Silva; Muhammad Torequl Islam; João Marcelo de Castro E Sousa; Ana Amélia de Carvalho Melo Cavalcante
Journal:  Oxid Med Cell Longev       Date:  2020-03-28       Impact factor: 6.543

8.  Development of Pancreatic Acinar Cell Metaplasia During Gastric Repair in a Rat Duodenal Contents Reflux Model.

Authors:  Yasuhiro Wada; Ken-Ichi Mukaisho; Shunpei Kanai; Takahisa Nakayama; Masahide Fukuda; Kazuhiro Mizukami; Tadayoshi Okimoto; Masaaki Kodama; Hiroyuki Sugihara; Kazunari Murakami; Ryoji Kushima
Journal:  Dig Dis Sci       Date:  2020-05-21       Impact factor: 3.199

9.  Is gastrectomy-induced high turnover of bone with hyperosteoidosis and increase of mineralization a typical osteomalacia?

Authors:  Takashi Ueyama; Yuta Yamamoto; Kazuki Ueda; Aiji Yajima; Yoshimasa Maeda; Yasunobu Yamashita; Takao Ito; Yoshihiro Tsuruo; Masao Ichinose
Journal:  PLoS One       Date:  2013-06-11       Impact factor: 3.240

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.